Back to Search
DEAN BAJORIN, MD
MD
Medical Oncology Physician
NPI: 1245277078Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
162402(NY)
Research & Publications (20)
Advances in urologic oncology: results progress from successful interdisciplinary research.
PMID 17158532·J Clin Oncol·2006
8-other
Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
PMID 11560966·J Clin Oncol·2001
8-other
Paclitaxel in the treatment of advanced urothelial cancer.
PMID 10680149·Oncology (Williston Park)·2000
6-review
Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract.
PMID 10908845·Eur J Cancer·2000
3-trial
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
PMID 10738226·Cancer·2000
3-trial
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
PMID 19636012·J Clin Oncol·2009
3-trial
Detection of circulating tumor cells in patients with urothelial cancer.
PMID 18836088·Ann Oncol·2009
8-other
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma.
PMID 19670454·Cancer·2009
3-trial
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.
PMID 19168670·Ann Oncol·2009
3-trial
Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor.
PMID 18626513·Nat Clin Pract Urol·2008
6-review
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.
PMID 18629841·Cancer·2008
6-review
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
PMID 18823036·Cancer·2008
8-other
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
PMID 19035902·BJU Int·2008
6-review
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.
PMID 18272914·Ann Oncol·2008
3-trial
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
PMID 18172902·Cancer·2008
8-other
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 18086794·J Clin Oncol·2008
8-other
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.
PMID 18829505·Clin Cancer Res·2008
8-other
Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
PMID 18073725·Nat Clin Pract Urol·2008
8-other
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.
PMID 17922873·BJU Int·2008
3-trial
Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
PMID 17998544·J Clin Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1245277078
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile